Hepatic arterial infusion chemotherapy combined with lenvatinib and PD‐1 inhibitors versus lenvatinib and PD‐1 inhibitors for HCC refractory to TACE

L Diao, C Wang, R You, B Leng, Z Yu… - Journal of …, 2024 - Wiley Online Library
Abstract Background and Aim The study aims to investigate the efficacy and safety of hepatic
arterial infusion chemotherapy (HAIC) combined with lenvatinib and immune checkpoint …
被引用次数：1 相关文章

Hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors versus lenvatinib and PD-1 inhibitors for HCC refractory to TACE.

L Diao, C Wang, R You, B Leng, Z Yu, Q Xu… - Journal of …, 2024 - europepmc.org
The study aims to investigate the efficacy and safety of hepatic arterial infusion
chemotherapy (HAIC) combined with lenvatinib and immune checkpoint inhibitors (ICIs) …

Hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors versus lenvatinib and PD-1 inhibitors for HCC refractory to TACE

L Diao, C Wang, R You, B Leng… - Journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Background and aim The study aims to investigate the efficacy and safety of hepatic arterial
infusion chemotherapy (HAIC) combined with lenvatinib and immune checkpoint inhibitors …